TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Withaferin A, Immune checkpoint blockers
Phytochemical Name Withaferin A (PubChem CID: 265237 )
Anticancer drug Name Immune checkpoint blockers (PubChem CID: / )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 796
Pair Name Withaferin A, Immune checkpoint blockers
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Immunomodulatory
Gene Regulation Up-regulation Expression CD274 hsa29126
In Vivo Model To establish the LLC syngeneic tumors, C57BL/6 mice were injected with a half million cells on the right flank and monitored until tumors were first palpable (2–3 mm diameter).
Result Our results demonstrate that WFA sensitizes NSCLC to α-PD-L1 in part via activation of ROS.
03. Reference
No. Title Href
1 Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer. Cancers (Basel). 2023 Jun 7;15(12):3089. doi: 10.3390/cancers15123089. Click
It has been 48132 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP